Core Insights - Brain science is reshaping the understanding of emotional issues, indicating that anxiety and depression are not merely psychological problems but are linked to pathological changes in brain neural circuits [2][3] - The concept of "pain emotion" is introduced, suggesting that chronic psychological discomfort can activate specific neural circuits, leading to persistent anxiety or depression [3][4] - The need for precise identification and intervention in emotional issues is emphasized, distinguishing between short-term and chronic anxiety [5] Group 1: Understanding Emotional Issues - The development of brain science clarifies the neural mechanisms behind emotional problems, focusing on learned changes in brain circuits rather than just psychological states [3] - Chronic anxiety is linked to molecular mechanisms that become reinforced in the brain, making it difficult to resolve simply through cognitive understanding [4] - Modern lifestyle factors, such as constant exposure to information via smartphones and social media, contribute to heightened sensitivity in neural circuits, increasing the prevalence of emotional issues [4] Group 2: Identification and Intervention Strategies - Accurate identification of emotional problems is crucial for effective intervention, with a focus on differentiating between short-term and chronic anxiety [5] - A layered judgment approach is proposed for assessing chronic anxiety, involving self-awareness, professional evaluation, and AI-assisted monitoring tools [5] - Multi-dimensional intervention strategies are recommended, including environmental changes, psychological counseling, and memory restructuring techniques [5][6] Group 3: Future of the Emotional Health Industry - Emotional issues represent a global public health challenge, creating significant demand for industry solutions, but the translation of brain science findings into practical applications requires collaboration among academia, industry, and research [7] - Innovative drug development is identified as a key area for translating brain science into marketable solutions, with a focus on creating targeted therapies that selectively inhibit overactive neural circuits [7] - The research team is optimistic about the potential for precision-targeted medications to be clinically available within the next 5 to 10 years, aiming for effective treatments for anxiety and depression similar to those for other common diseases [7]